HRP20200588T1 - Završno filtriranje u više koraka - Google Patents

Završno filtriranje u više koraka Download PDF

Info

Publication number
HRP20200588T1
HRP20200588T1 HRP20200588TT HRP20200588T HRP20200588T1 HR P20200588 T1 HRP20200588 T1 HR P20200588T1 HR P20200588T T HRP20200588T T HR P20200588TT HR P20200588 T HRP20200588 T HR P20200588T HR P20200588 T1 HRP20200588 T1 HR P20200588T1
Authority
HR
Croatia
Prior art keywords
pore size
her2 antibody
filter
her2
solution
Prior art date
Application number
HRP20200588TT
Other languages
English (en)
Inventor
Roberto Falkenstein
Klaus Schwendner
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20200588T1 publication Critical patent/HRP20200588T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Claims (2)

1. Postupak za proizvodnju anti-HER2 protutijela, naznačen time, da sadrži sljedeće korake: a) kultiviranje stanice koja sadrži nukleinsku kiselinu koja kodira anti-HER2 protutijelo, b) dobivanje anti-HER2 protutijela iz stanice ili kultivacijskog medija, c) pročišćavanje anti-HER2 protutijela s jednim ili više koraka kromatografije i dobivanje otopine anti-HER2 protutijela, d) dodavanje šećera i deterdženta u otopinu, e) koncentriranje otopine anti-HER2 protutijela do koncentracije od 125 g/l ili više, postupkom odabranim od dijafiltracije ili filtracije tangencijalnog protoka, i f) nanošenje otopine anti-HER2 protutijela iz prethodnog koraka na kombinaciju prve i druge filterske jedinice, pri čemu prva filterska jedinica sadrži predfilter s veličinom pora od 3,0 µm i glavni filter s veličinom pora od 0,8 µm, a druga filterska jedinica sadrži predfilter s veličinom pora od 0,45 µm i glavni filter s veličinom pora od 0,22 µm, s tlakom od 0,75 bara ili manje, i na taj način proizvodnja anti-HER2 protutijela.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time, da je korak pročišćavanja s afinitetnom kromatografijom proteina A i barem jedan korak odabran između kromatografije kationskom izmjenom, kromatografije anionskom izmjenom i hidrofobne interakcijske kromatografije.
HRP20200588TT 2009-10-01 2020-04-14 Završno filtriranje u više koraka HRP20200588T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09012460 2009-10-01
EP16188558.7A EP3133083B1 (en) 2009-10-01 2010-09-29 Multistep final filtration

Publications (1)

Publication Number Publication Date
HRP20200588T1 true HRP20200588T1 (hr) 2020-07-10

Family

ID=41466840

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20161693TT HRP20161693T1 (hr) 2009-10-01 2016-12-12 Završno filtriranje imunoglobulina u više koraka
HRP20200588TT HRP20200588T1 (hr) 2009-10-01 2020-04-14 Završno filtriranje u više koraka

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HRP20161693TT HRP20161693T1 (hr) 2009-10-01 2016-12-12 Završno filtriranje imunoglobulina u više koraka

Country Status (21)

Country Link
US (3) US20120231506A1 (hr)
EP (3) EP3133083B1 (hr)
JP (1) JP5458183B2 (hr)
KR (3) KR101508044B1 (hr)
CN (3) CN103980346A (hr)
AU (1) AU2010302662B2 (hr)
BR (1) BR112012004054B1 (hr)
CA (1) CA2773674C (hr)
CY (1) CY1118577T1 (hr)
DK (1) DK2483305T3 (hr)
ES (2) ES2604103T3 (hr)
HK (2) HK1200178A1 (hr)
HR (2) HRP20161693T1 (hr)
HU (1) HUE030186T2 (hr)
IL (2) IL217626A (hr)
LT (1) LT2483305T (hr)
MX (1) MX342442B (hr)
PL (2) PL2483305T3 (hr)
PT (1) PT2483305T (hr)
SI (2) SI2483305T1 (hr)
WO (1) WO2011039274A1 (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
CN111007242A (zh) * 2019-12-20 2020-04-14 苏州和迈精密仪器有限公司 基于多层高分子多孔膜的荧光免疫检测方法、装置及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4488961A (en) 1982-09-29 1984-12-18 E. I. Du Pont De Nemours And Company One-way filter unit
US4592848A (en) * 1984-12-11 1986-06-03 Pabst Richard E Flow through filter with backflush clearing capability
CS247484B1 (cs) 1985-04-12 1987-01-15 Eva Hamsikova Způsob přípravy imunoglobulinu proti lidským Iymfocytům
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
DE3818860A1 (de) 1988-06-03 1989-12-07 Seitz Filter Werke Filterelement
DE122004000008I1 (de) 1991-06-14 2005-06-09 Genentech Inc Humanisierter Heregulin Antikörper.
DE4204444C1 (hr) 1992-02-14 1993-05-19 Krankenhausentsorgungs Gmbh, 1000 Berlin, De
WO1997004801A1 (en) 1995-07-27 1997-02-13 Genentech, Inc. Stabile isotonic lyophilized protein formulation
DE69739673D1 (de) 1996-11-27 2009-12-31 Genentech Inc Affinitätsreinigung von Polypeptid-Proteinen auf einer Protein A Matrix
IL139035A0 (en) 1998-05-06 2001-11-25 Genentech Inc Protein purification by ion exchange chromatography
US6984494B2 (en) * 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
JP4460302B2 (ja) 2002-02-05 2010-05-12 ジェネンテック インコーポレイテッド タンパク質精製法
CN1671741A (zh) * 2002-06-21 2005-09-21 拜奥根Idec公司 浓缩抗体的缓冲剂制剂及其使用方法
AU2003271095B2 (en) * 2002-10-04 2009-06-11 Kirin Beer Kabushiki Kaisha Human artificial chromosome (HAC) vector
WO2004087761A1 (ja) 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
GB0316560D0 (en) * 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
EP1773383B1 (en) * 2004-05-27 2012-09-12 Jon A. Weidanz Antibodies as t cell receptor mimics, methods of production and uses thereof
EP1786273B1 (en) * 2004-08-20 2018-11-14 ProMetic BioSciences Ltd. Sequential protein isolation and purification schemes by affinity chromatography
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
CA2586130A1 (en) * 2004-11-22 2006-05-26 Oxygenix Co., Ltd. Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
WO2006096488A2 (en) * 2005-03-08 2006-09-14 Pharmacia & Upjohn Company Llc Composition comprising human igg2 antibody and chelating agent
JPWO2007018316A1 (ja) 2005-08-09 2009-02-19 武田薬品工業株式会社 癌の予防・治療剤
US9109015B2 (en) * 2006-11-01 2015-08-18 Biogen Ma Inc Method of isolating biomacromolecules using low pH and divalent cations
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
EP2170949B1 (en) * 2007-07-17 2012-12-26 F. Hoffmann - La Roche AG Variable tangential flow filtration
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
MX2011004558A (es) 2008-10-29 2011-06-01 Wyeth Llc Procedimientos para la purificacion de moleculas de union a antigeno de un unico dominio.
SI2914612T1 (sl) * 2012-10-30 2019-03-29 F. Hoffmann-La Roche Ag Čiščenje polipeptidov z uporabo dvostopenjske tangencialne ultrafiltracije

Also Published As

Publication number Publication date
ES2604103T3 (es) 2017-03-03
US20180009878A1 (en) 2018-01-11
LT2483305T (lt) 2016-11-25
EP2483305B1 (en) 2016-09-21
CA2773674A1 (en) 2011-04-07
PL2483305T3 (pl) 2017-03-31
IL217626A (en) 2017-12-31
JP2013505733A (ja) 2013-02-21
AU2010302662B2 (en) 2015-11-26
KR20120053522A (ko) 2012-05-25
AU2010302662A1 (en) 2012-02-09
CY1118577T1 (el) 2017-07-12
MX2012003727A (es) 2012-04-30
HK1210183A1 (en) 2016-04-15
CN103980346A (zh) 2014-08-13
BR112012004054A2 (pt) 2020-08-11
HRP20161693T1 (hr) 2017-02-24
EP3715369A1 (en) 2020-09-30
MX342442B (es) 2016-09-29
KR101718301B1 (ko) 2017-03-20
PL3133083T3 (pl) 2020-09-07
CN104610447A (zh) 2015-05-13
WO2011039274A1 (en) 2011-04-07
US20120231506A1 (en) 2012-09-13
KR20140091763A (ko) 2014-07-22
BR112012004054B1 (pt) 2021-09-08
KR20160104739A (ko) 2016-09-05
EP2483305A1 (en) 2012-08-08
HUE030186T2 (en) 2017-04-28
PT2483305T (pt) 2016-11-04
US20200291097A1 (en) 2020-09-17
US11891430B2 (en) 2024-02-06
JP5458183B2 (ja) 2014-04-02
CN102574913A (zh) 2012-07-11
DK2483305T3 (en) 2016-10-24
SI2483305T1 (sl) 2017-01-31
HK1200178A1 (en) 2015-07-31
EP3133083B1 (en) 2020-02-19
SI3133083T1 (sl) 2020-07-31
KR101653471B1 (ko) 2016-09-01
ES2787403T3 (es) 2020-10-16
IL255658A (en) 2018-01-31
KR101508044B1 (ko) 2015-04-07
EP3133083A1 (en) 2017-02-22
CA2773674C (en) 2017-08-29

Similar Documents

Publication Publication Date Title
HRP20150761T4 (hr) Postupak za pročišćavanje lipopeptida
US10053489B2 (en) Method for purifying antibody
HRP20191848T1 (hr) Postupci odstranjivanja kontaminanta uporabom membranske kromatografije ionskom izmjenom s premještanjem autohtonog proteina
Zhou et al. Influence of hydrophobic/hydrophilic fractions of extracellular organic matters of Microcystis aeruginosa on ultrafiltration membrane fouling
AR121861A2 (es) MÉTODO PARA PREPARAR UNA COMPOSICIÓN DE IgG ENRIQUECIDA A PARTIR DE PLASMA
HRP20201118T1 (hr) Izolacija i pročišćavanje prot-il-13 protutijela uporabom protein a afinitetne kromatografije
HRP20200588T1 (hr) Završno filtriranje u više koraka
RU2015120458A (ru) Очистка полипептидов с использованием двухстадийной ультрафильтрации в тангенциальном потоке
RU2014125063A (ru) Очистка белка с использованием бис-трис буфера
ATE539149T1 (de) Reinigungsverfahren zur isolierung von gereinigtem vesikulärem stomatitisvirus aus zellkultur
RU2012154652A (ru) Устройство для очистки белка и способ применения указанного устройства
HRP20180182T1 (hr) Pravilno presavijeni etanercept visoke čistoće i izvanrednog prinosa
JP2008514237A5 (hr)
EP2565206A3 (en) Antibody purification by cation exchange chromatography
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
BR112013020196A2 (pt) meio, método e uso de filtragem para purificação de fluidos, método para produção de composição ferro-prata e pó de ferro-prata
Versari et al. Concentration of grape must by nanofiltration membranes
WO2010151632A8 (en) Protein purification by caprylic acid (octanoic acid ) precipitation
US20190330269A1 (en) Method for purifying antibodies using pbs
ATE547521T1 (de) Verfahren zur reinigung von nukleinsäure
CN102796149A (zh) 一种依替米星的连续分离纯化工艺
CN104892710A (zh) 一种纯化还原型β-烟酰胺腺嘌呤二核苷酸的方法
WO2006064373A3 (en) Methods of purifying immunologlobulins
CN103497248A (zh) 一种从细胞培养上清中分离纯化抗体的方法
WO2011130809A3 (en) Fractionation of ions from aqueous solutions by electrodialysis using monovalent selective membranes